about
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?Fibrates and cholestasisDifferential Roles of Peroxisome Proliferator-Activated Receptor-α and Receptor-γ on Renal Crystal Formation in Hyperoxaluric RodentsLow protein diet inhibits uric acid synthesis and attenuates renal damage in streptozotocin-induced diabetic rats.Saroglitazar for the treatment of dyslipidemia in diabetic patients.The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease.Safety considerations with fenofibrate/simvastatin combination.The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats.Pharmacological management of diabetic dyslipidemia.Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.Effects of Low-Protein Diets Supplemented with Ketoacid on Expression of TGF-β and Its Receptors in Diabetic Rats.An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors.Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
P2860
Q33646780-1CF51D43-7572-460A-9ED7-6A4D47B15A8AQ33776187-2B6EDB46-A32B-4E22-BF79-F1C215E596F5Q35889448-ACDFEFDF-9561-454A-9329-E4ECCC45549FQ36679676-457378F2-ACA2-42EA-AF1C-6F0CF9649BC2Q37686722-60F73125-4562-4856-A156-76C619601D32Q38352759-342017C5-FAF9-4865-8EB8-0A58532EA5F4Q38468908-FA06157C-213B-4E8E-8FA3-91D66AB4758CQ38541832-62549CFF-E158-4B24-BE65-68A961746420Q38911782-01940B2D-B62B-4263-85E3-FB5278A31469Q39015072-A09CE7CF-8754-424E-9DCA-802B114F1E3FQ39584105-72BED1C2-416A-4E36-A435-6AC23DB0ED3BQ41862385-ED10D88C-DD29-4F45-9479-1B8B4E26C340Q53684513-19D75B73-AABD-4487-872A-205635715417Q58804230-AC439B2C-B944-4072-B8B7-D18A56FD14B7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fenofibrate and the kidney: an overview.
@en
type
label
Fenofibrate and the kidney: an overview.
@en
prefLabel
Fenofibrate and the kidney: an overview.
@en
P2860
P356
P1476
Fenofibrate and the kidney: an overview
@en
P2093
Matilda Florentin
P2860
P304
P356
10.1111/ECI.12068
P577
2013-03-11T00:00:00Z